|
EconStor >
Stockholm School of Economics >
EFI - The Economic Research Institute, Stockholm School of Economics >
SSE/EFI Working Paper Series in Economics and Finance, EFI - The Economic Research Institute, Stockholm School of Economics >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10419/56355
|
| | |
Full metadata record
| DC Field | | Value | | Language |
| dc.contributor.author | | Jönsson, Bengt | | en_US |
| dc.contributor.author | | Lundkvist, Jonas | | en_US |
| dc.contributor.author | | Persson, Björn | | en_US |
| dc.date.accessioned | | 2012-03-28T13:11:05Z | | - |
| dc.date.available | | 2012-03-28T13:11:05Z | | - |
| dc.date.issued | | 2002 | | en_US |
| dc.identifier.uri | | http://hdl.handle.net/10419/56355 | | - |
| dc.language.iso | | swe | | en_US |
| dc.publisher | | Ekonomiska Forskningsinst. Stockholm | | en_US |
| dc.relation.ispartofseries | | SSE/EFI Working Paper Series in Economics and Finance 505 | | en_US |
| dc.subject.jel | | I11 | | en_US |
| dc.subject.ddc | | 330 | | en_US |
| dc.subject.stw | | Pharmazeutisches Produkt | | en_US |
| dc.subject.stw | | Schweden | | en_US |
| dc.subject.stw | | Pharmazeutische Forschung | | en_US |
| dc.title | | Nya läkemedel i Sverige: Innovationshöjd, prissättning och marknadsframgång | | en_US |
| dc.type | | Working Paper | | en_US |
| dc.identifier.ppn | | 353676365 | | en_US |
| dc.rights | | http://www.econstor.eu/dspace/Nutzungsbedingungen | | en_US |
| Appears in Collections: | | SSE/EFI Working Paper Series in Economics and Finance, EFI - The Economic Research Institute, Stockholm School of Economics
|
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.
|